Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-12 5:09 pm Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | MFN Partners Management LP | 2,427,677 7.15% | 939,803 (+63.16%) | View |
| 2021-02-08 10:19 am Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | FMR LLC | 2,719,711 8.008% | 188,233 (+7.44%) | View |
| 2021-02-05 11:24 am Unchanged | 13G | CYCLERION THERAPEUTICS INC CYCN | American Endowment Foundation | 2,660,546 7.8% | 0 (Unchanged) | View |
| 2020-09-09 3:52 pm Sale | 13G | CYCLERION THERAPEUTICS INC CYCN | BlackRock Inc. BLK | 1,581,905 4.7% | -34,776 (-2.15%) | View |
| 2020-08-10 4:16 pm Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 6,196,063 18.3% | 6,196,063 (New Position) | View |
| 2020-02-14 4:21 pm Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | American Endowment Foundation | 2,660,546 8.7% | 2,660,546 (New Position) | View |
| 2020-02-14 09:31 am Sale | 13G | CYCLERION THERAPEUTICS INC CYCN | Camber Capital Management LP | 0 0% | -1,561,915 (Position Closed) | View |
| 2020-02-13 5:07 pm Sale | 13G | CYCLERION THERAPEUTICS INC CYCN | MFN Partners Management LP | 1,487,874 5.4% | -18,978 (-1.26%) | View |
| 2020-02-07 11:16 am Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | FMR LLC | 2,531,478 9.215% | 2,531,478 (New Position) | View |
| 2020-02-07 08:45 am Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | BlackRock Inc. BLK | 1,616,681 5.9% | 1,616,681 (New Position) | View |
| 2020-02-03 5:02 pm Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | Artal International S.C.A. | 1,861,584 6.8% | 1,861,584 (New Position) | View |
| 2019-12-27 5:02 pm Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | EcoR1 Capital LLC | 1,811,000 6.6% | 1,811,000 (New Position) | View |
| 2019-06-17 11:26 am Purchase | 13G | CYCLERION THERAPEUTICS INC CYCN | Camber Capital Management LP | 1,561,915 5.7% | 1,561,915 (New Position) | View |